Physician profile
Joseph Gil
NPI 1699035634
$6,806.05
in general payments reported to CMS, 2019-2025
14 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,658 · 2020: $10.12 · 2021: $167 · 2022: $516 · 2023: $299 · 2024: $934 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $955 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $955.02 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,505.11 | 2019 | |
| Acumed LLC | $768.94 | 2019-2025 | Acumed, Innate Implant, Acumed |
| Synthes Gmbh | $750.00 | 2022-2024 | |
| Zimmer Biomet Holdings, INC. | $464.79 | 2023-2024 | A.L.P.S., Affixus |
| Gemini Medical LLC | $348.70 | 2019 | |
| Trimed, INC. | $326.64 | 2019-2020 | |
| Axogen | $172.16 | 2019-2021 | |
| Kairos Surgical INC | $138.45 | 2019 | |
| Abbott Laboratories | $117.96 | 2023 | Proclaim |
| Endo Pharmaceuticals INC. | $111.22 | 2019 | |
| Integra Lifesciences Corporation | $50.06 | 2019 | |
| Smith+Nephew, INC. | $38.43 | 2021 | |
| Stryker Corporation | $13.59 | 2025 | Pangea |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Gil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.